Trial intelligence / Profile preview

ECG Effects of Chloroquine vs Piperaquine in Healthy Subjects

NCT02192944Phase 4Completed

Sponsor
University of Oxford
Start
Jul 2014
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of piperaquine and chloroquine in malaria, sponsored by University of Oxford. Started Jul 2014; status: completed.

02

Drugs

piperaquinechloroquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02192944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02192944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call